mats-ola s kalgraff uretra lower urinary tract symptoms revisited: a broader clinical perspective....

54

Upload: vanquynh

Post on 19-Mar-2019

237 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 2: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 3: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Mats-Ola S Kalgraff • M.D Umeå University Sweden

• Master in Sexology Aalborg University Denmark

• Volvat Med Senter Oslo

• Ferring Scandinavia

• Kristiansund Hospital Chief of Urology Department

• Avtalehjemmel Urologi Moelv

• Avtalehjemmel Urologi Brumundal. Multidisciniplenary team

• Mosjøen og Haugesund Overlege urologi

Page 4: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 5: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 6: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

ED, kommer med sykdom, ikke med alder !

Med alder kommer sykdom !!!

Page 7: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

En God Erektion Kräver

Lust och Tillgång på Sexuella känslor Kognitiva funktioner Intakt nerv kommunikation CNS – periferi Responsiv glatt muskulatur i Penis Fungerande Endotelial reglering av kärltonus Testosteron i tillräcklig mängd Thyreoidea funktion i god ordning

Page 8: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Billups K, Friedrich S. Presenterat på: AUA; maj 2000; Atlanta, Ga. J Urol. 2000;163(4) Abstract 655. Braun M et al. Int J Impot Res. 2000;12:305–311. Burchardt M et al. J Urol. 2000;164:1188–1191. Levine L, Kloner R. Am J Cardiol. 2000;86:1210–1213. Pritzker MR. Circulation. 1999;100(suppl I):I-711. Abstract 3751. Seftel A. J Urol. 2004;171:2341–2345.

• 68 % av män med hypertoni har ED

• 60 % av män med ED har dyslipidemi

• 56 % av män med ED har positivt stresstest

• 40 % av män med ED har betydande koronarkärls-ocklusioner

• 20 % av män med ED har diabetes mellitus

• 11 % av män med ED har depression

ED har samband med andra allvarliga behandlingsbara sjukdomar

Page 9: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Er mannen før kort for sin vekt?

menn dør unge og har kortere levetid

Page 10: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 11: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Menn tilsynelatende så lik men allikevel så ulik !

??????

Page 12: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 13: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 14: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

HUSK DISSE

Page 15: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 16: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

3.1.5 Risk Factors and underlying causes

3.1.5.1 Risk factors

Risk factors include many different factors from various areas,

including genetic, psychological state,

recurrent physical trauma and endocrine factors.

Chronic pelvic pain

CPPS og prostatit ses frekvent hos hypogonade menn

ISSM Dean

Page 17: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 18: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 19: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

refguidelines eua /CPPS

Page 20: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Detrusor

overaktivi

tet

BPH

Blære

Tumor

Stein

Nedre

urinveier

Ned

re

Annet

Neurolog

isk

sykdom

Kronisk

e

bekken

smerter

Nocturn

polyuri

OAB

Fremmen

de

Kropp

UVI

Striktur

Uretra

Page 21: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Lower urinary tract symptoms revisited: a broader clinical perspective.

Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT, Roehrborn CG.

Author information Abstract

CONTEXT:

The term "lower urinary tract symptoms" (LUTS) was introduced to dissociate male urinary symptoms from any implied site of symptom origin, such as the prostate.

OBJECTIVE:

To consider a more expansive view of LUTS, moving beyond an organocentric focus.

EVIDENCE ACQUISITION:

Review of the available literature by a consensus panel.

EVIDENCE SYNTHESIS:

A consensus group reviewed the literature and developed a conceptual framework to facilitate research and clinical practice in patients with LUTS, following steps outlined in the Delphi

procedure. Committee discussion, with presentations and review of existing literature and knowledge at four separate occasions, and extensive review and discussion of draft documents

encapsulating group views followed. Consensus group findings included evidence that LUTS increase with age and are prevalent in both male and female patients, with differences in the

prevalence of individual storage, voiding, and postmicturition symptoms representing underlying pathophysiologic factors between the sexes. Additionally, it was recognised that patients

often have underlying and overlapping pathophysiologic mechanisms that may be related to the expression of LUTS and that this global approach to LUTS reflects our contemporary

recognition of the lower urinary tract as an integrated functional unit. To improve the current management of patients, education and awareness regarding LUTS, its causes, and

associated comorbidities are needed. Major limitations of this work are the potential interpretive bias introduced by prior perceptions and the nature of the study populations drawn

conventionally from secondary care.

CONCLUSIONS:

In conclusion, it is misleading to attribute individual symptoms to sex differences or to a specific underlying

organ. LUTS are a non-sex-specific, non-organ-specific group of symptoms, which are sometimes age-

related and progressive. A need exists to increase education and awareness regarding LUTS, its causes, and

associated comorbidities, and to assess and treat men and women for all LUTS, not just selected symptoms.

PMID: 18423969 DOI: 10.1016/j.eururo.2008.03.109

Page 22: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Noen av de mest vanlige tilstanden før LUTS hos menn presentert her nedenfor

Akutt urinretensjon, smertefull palpabel eller perkutorisk blære, når pas ikke kan urinere

Kronisk retensjon ; ikke smertefull blære som man kan palpere eller perkutere etter det at

pas har latet vannet, ofte er pas inkontinent

Bladder outlet obstruction BOO

en term før obstruksjon under tømming, karakteristisk er økt detrusor trykk og svak stråle

Benign prostatic obstruction BPO er en variant av BOO .

BPH er eg en histologisk beskrivning

Detrusor overactivity (DO) er en urodynamisk observation karakterisert av ikke frivillige

sammentrekninger av blærens muskulatur under fyllnadsfas, Disse kan være spontane eller

fremprovosert

Overactive bladder syndrome OAB karakterisert av urge med eller uten inkontinens with or

without urgency urinary incontinence, vanlitvis med økt frekvens av tømminger dagtid og

nattlig urinering ,om man ikke funnet infeksjon eller annen åpenlys grunn til sykdom.

Page 23: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Man eller Kvinne ?

Page 24: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 25: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 26: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 27: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

void

ing

-slo

w s

tream

-sp

litting o

r spra

yin

g

-in

term

itte

ncy

-str

ain

ing

-te

rmin

al dribblin

g

voiding

-slow stream

-splitting or spraying

-intermittency

-straining

-terminal dribbling

post micturition

-post micturition dribble

-feeling of incomplete emptying

storage

-frequency

-urgency

-nocturia

-incontinence

Page 28: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

○ IPSS

○ 7 spørsmål tømmer du deg?

○ Mindre tid en 2 timer mellon urinering

○ Må du stoppe og starte flere ggr under vannlating

○ Er det vanskelig att utsette vannlating

○ Har du svak stråle

○ Må du presse?

○ Hvor ofte tisser du om tisse om natten

○ X/35

○ QoL skala 1-6

○ 4

21/35

Page 29: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

○ QoL skala 1-6

○ EN PAS SCORER IPSS 4/35 QoL 6/6

○ VAD KAN JEG GJØRE FOR DEG SÅ AT DU

SCORER 1 ?

Spør

Page 30: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 31: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Fortell meg

At jeg ikke har kreft !

Page 32: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Post voidal residual

Page 33: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Downloaded from: Campbell-Walsh Urology (on 28 January 2010 09:32 AM)

© 2007 Elsevier

Page 34: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 35: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Per Rectum

Two reasons to not palpate the prostate

• No finger

• No hole

Page 36: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Brown finger Award

DRU Digital rektal

undersökelse

Page 37: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Transrektalt ultralyd • EKO

• Størrelse

• Vevsprøve

Page 38: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

38

Signalerer aktivitet i prostata

• Har man prostata har man PSA

• Kan vara kreft

• Infeksjon, stor kjertel , kateter ,

vevsprøve , sykling, sexleketøy

PSA; PROSTATA SPECIFIKT ANTIGEN

Page 39: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Patients with Pca

Pat LUTS

All men with prostate

No prostate

Page 40: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

PSA Velocity

• Med vilken hastighet

PSA ökar med tiden

• >0.75ug/l och år

0,

1,3

2,5

3,8

5,

2004 2005 2006 2007

pat 1

pat 2

Page 41: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

TRUL

• Volume

• 5 i PSA

• 20ml vs 80 ml

• Densitet PSA/ML >0,15 indicates cancer

41

Page 42: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Tabell 3: Risiko for prostatakreft sammenholdt med lave PSA verdier.

PSA nivå (ng/ml) Risiko for prostatakreft

0-0,5 6,6% 0,6-1 10,1% 1,1-2 17,0% 2,1-3 23%

3,1-4 26,9%

”US prevention study” (Thompson et al.,

2004). Frekvensen av prostatakreft

sammenholdt med serum PSA hos 2950

menn i placebo-armen og med normal

PSA-verdier vises i Tabell 3. Alders

spredningen ved biopsi var 62-91 år.

Page 43: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Duodart

kombinasjon tamsulosin og dutasteride

Proscar

Finasteride

HUSK

Tamsulosin minker ikke prostata

Finasteride og dutasteride minker volum

Page 44: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

5 overflow

Page 45: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Makroskopisk hematuri

Page 46: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Overflow

IKKE FRIVILLIG LEKKASJE FOR URIN.

SPESIELLT OM NATTEN

Pasienten ser gravid ut

FARLIG !

Nyresvikt

Øvre urinveisinfektion

Sett kateter,

UNDERSØK PAS NØYE ETTERPÅ

Page 47: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Makroskopisk Hematuri

• Blod synlig for øye

• Er alltid sant !

• Er kreft til motsatt er bevist

• Cystoskopi

CT scan

Page 48: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Prostata

BPH

alfablokkad

femalfareduktashemmer

kombo

kirurgi

Prostatitt

NSAID

AlfaBlokkad

Tricykliske antidepressive

Antibiotika ?

PCa

helt eget foredrag

Page 49: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Blære

stein

tumor

oab

neurogen skade

inkontinens ufrivillig NB!

IC ??

Page 50: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Skrotum

hydrocele

varicocele

orkitt

spermatocele

tumor( unge menn)

epididydimitt

Page 51: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Penis/uretra

Peyronies

Striktur

uretritt

peniskreft meget uvanlig i vest

fimose

Page 52: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,

Etter sterilisering/vasektomi

Blødning

Infeksjon

skrotala smerter

er også diskutert i sammenheng med

prostatkreft - når er der ingen link ?

alzheimer-link?

metabole sykdommer —finnes link ?

hypogonadisme-link?

hypogonadisme er linket til prostatkreft

forskningstes

vasektomi—hypogonadisme—prostatakreft

Page 53: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,
Page 54: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,